Professor Carolyn Sue is a neurologist and internationally regarded for her work in Parkinson’s disease and mitochondrial disease. She is Australia’s leading mitochondrial disease clinician, running the country’s largest tertiary referral clinic and benchmarking mitochondrial disease practice. She was awarded a Member of the Order of Australia for her significant service to medicine, particularly mitochondrial disease.

Professor Sue’s discovery research has led to improved diagnosis and treatment of mitochondrial diseases and identified the prevalence of mitochondrial DNA mutations in the Australian community. As an esteemed health and medical researcher, she was appointed Executive Director of the Kolling Institute in 2019.